Glucocorticoid-induced degradation of glycogen synthase kinase-3 protein is triggered by serum- and glucocorticoid-induced protein kinase and Akt signaling and controls β-catenin dynamics and tight junction formation in mammary epithelial tumor cells

Molecular Endocrinology

Volumn 21, Issue 10, 2007, Pages 2403-2415

  Failor, Kim L ^a   Desyatnikov, Yelena ^a   Finger, Lindsay A ^a   Firestone, Gary L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; DEXAMETHASONE; GLUCOCORTICOID; GLYCOGEN SYNTHASE KINASE 3; PROTEIN KINASE; PROTEIN KINASE B;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EPITHELIUM TUMOR; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; TUMOR CELL; UBIQUITINATION;

ANIMALS; BETA CATENIN; CELL LINE, TUMOR; DEXAMETHASONE; EPITHELIAL CELLS; GLYCOGEN SYNTHASE KINASE 3; IMMEDIATE-EARLY PROTEINS; MAMMARY GLANDS, ANIMAL; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; SERINE; TIGHT JUNCTIONS; UBIQUITIN;

EID: 34948894886     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2007-0143     Document Type: Article

References (69)

1. Anderson, JM., Van Itallie CM, Fanning AS 2004 Setting up a selective barrier at the apical junction complex. Curr Opin Cell Biol 16:140-145
2. Cereijido M, Shoshani L, Contreras RG 2000 Molecular physiology and pathophysiology of tight junctions. I. Biogenesis of tight junctions and epithelial polarity. Am J Physiol Gastrointest Liver Physiol 279:G477-G482
3. Cereijido M, Valdés J, Shoshani L, Contreras RG 1998 Role of tight junctions in establishing and maintaining cell polarity. Annu Rev Physiol 60:161-177
4. Dragsten PR, Blumenthal R, Handler JS 1981 Membrane asymmetry in epithelia: is the tight junction a barrier to diffusion in the plasma membrane? Nature 294: 718-722
5. Gonzalez-Mariscal L, Betanzos A, Nava P, Jaramillo BE 2003 Tight junction proteins. Prog Biophys Mol Biol 81:1-44
6. Madara JL 1998 Regulation of the movement of solutes across tight junctions. Annu Rev Physiol 60:143-159
7. Shin K, Fogg VC, Margolis B 2006 Tight junctions and cell polarity. Annu Rev Cell Dev Biol 22:207-235
8. van Meer G, Simons K 1986 The function of tight junctions in maintaining differences in lipid composition between the apical and the basolateral cell surface domains of MDCK cells. EMBO J 5:1455-1464
9. Gumbiner BM 1996 Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 84:345-357
10. Nagafuchi A 2001 Molecular architecture of adherens junctions. Curr Opin Cell Biol 13:600-603
11. Gumbiner B, Stevenson B, Grimaldi A 1988 The role of the cell adhesion molecule uvomorulin in the formation and maintenance of the epithelial junctional complex. J Cell Biol 107:1575-1587
12. Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S, Tsukita S, Tsukita S 1993 Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol 123:1777-1788
13. Mandell KJ, Parkos CA 2005 The JAM family of proteins. Adv Drug Deliv Rev 57:857-867
14. Van Itallie CM, Anderson JM 2006 Claudins and epithelial paracellular transport. Annu Rev Physiol 68:403-429
15. Wheelock MJ, Johnson KR 2003 Cadherins as modulators of cellular phenotype. Annu Rev Cell Dev Biol 19:207-235
16. Denker BM, Nigam SK 1998 Molecular structure and assembly of the tight junction. Am J Physiol 274:F1-F9
17. Mitic LL, Anderson JM 1998 Molecular architecture of tight junctions. Annu Rev Physiol 60:121-142
18. Nusrat A, Turner JR, Madara JL 2000 Molecular physiology and pathophysiology of tight junctions. IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells. Am J Physiol Gastrointest Liver Physiol 279:G851-G857
19. Nguyen DA, Neville MC 1998 Tight junction regulation in the mammary gland. J Mammary Gland Biol Neoplasia 3:233-246
20. Linzell JL, Peaker M 1974 Changes in colostrum composition and in the permeability of the mammary epithelium at about the time of parturition in the goat. J Physiol 243:129-151
21. Berga SE 1984 Electrical potentials and cell-to-cell dye movement in mouse mammary gland during lactation. Am J Physiol 247:C20-C25
22. Zettl KS, Sjaastad MD, Riskin PM, Parry G, Machen TE, Firestone GL 1992 Glucocorticoid-induced formation of tight junctions in mouse mammary epithelial cells in vitro. Proc Natl Acad Sci USA 89:9069-9073
23. Itoh M, Bissell MJ 2003 The organization of tight junctions in epithelia: implications for mammary gland biology and breast tumorigenesis. J Mammary Gland Biol Neoplasia 8:449-462
24. Buse P, Woo PL, Alexander DB, Cha HH, Reza A, Sirota ND, Firestone GL 1995 Transforming growth factor-α abrogates glucocorticoid-stimulated tight junction formation and growth suppression in rat mammary epithelial tumor cells. J Biol Chem 270:6505-6514
25. Guan Y, Woo PL, Rubenstein EM, Firestone GL 2002 Transforming growth factor-α abrogates the glucocorticoid stimulation of tight junction formation and reverses the steroid-induced down-regulation of fascin in rat mammary epithelial tumor cells by a Ras-dependent pathway. Exp Cell Res 273:1-11
26. Wong V, Ching D, McCrea PD, Firestone GL 1999 Glucocorticoid down-regulation of fascin protein expression is required for the steroid-induced formation of tight junctions and cell-cell interactions in rat mammary epithelial tumor cells. J Biol Chem 274:5443-5453
27. Woo PL, Cha HH, Singer KL, Firestone GL 1996 Antagonistic regulation of tight junction dynamics by glucocorticoids and transforming growth factor-β in mouse mammary epithelial cells. J Biol Chem 271:404-412
28. Woo PL, Ching D, Guan Y, Firestone GL 1999 Requirement for Ras and phosphatidylinositol 3-kinase signaling uncouples the glucocorticoid-induced junctional organization and transepithelial electrical resistance in mammary tumor cells. J Biol Chem 274:32818-32828
29. Woo PL, Cercek A, Desprez PY, Firestone GL 2000 Involvement of the helix-loop-helix protein Id-1 in the glucocorticoid regulation of tight junctions in mammary epithelial cells. J Biol Chem 275:28649-28658
30. Rubenstein NM, Guan Y, Woo PL, Firestone GL 2003 Glucocorticoid down-regulation of RhoA is required for the steroid-induced organization of the junctional complex and tight junction formation in rat mammary epithelial tumor cells. J Biol Chem 278:10353-10360
31. Rubenstein NM, Chan JF, Kim JY, Hansen SH, Firestone GL 2005 Rnd3/RhoE induces tight junction formation in mammary epithelial tumor cells. Exp Cell Res 305:74-82
32. Rubenstein NM, Callahan JA, Lo DH, Firestone GL 2007 Selective glucocorticoid control of Rho kinase isoforms regulate cell-cell interactions. Biochem Biophys Res Commun 354:603-607
33. Guan Y, Rubenstein HM, Failor KL, Woo PL, Firestone GL 2004 Glucocorticoids control β-catenin protein expression and localization through distinct pathways that can be uncoupled by disruption of signaling events required for tight junction formation in rat mammary epithelial tumor cells. Mol Endocrinol 18:214-227
34. Logan CY, Nusse R 2004 The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20:781-810
35. Hart M, Concordet JP, Lassot I, Albert I, del los Santos R, Durand H, Perret C, Rubinfeld B, Margottin F, Benarous R, Polakis P 1999 The F-box protein β-TrCP associates with phosphorylated β-catenin and regulates its activity in the cell. Curr Biol 9:207-210
36. Welsh GI, Stokes CM, Wang X, Sakave H, Ogawa W, Kasuga M, Proud CG 1997 Activation of translation initiation factor eIF2B by insulin requires phosphatidyl inositol 3-kinase. FEBS Lett 410:418-422
37. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA 1995 Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378:785-789
38. Dai F, Yu L, He H, Chen Y, Yu J, Yang Y, Xu Y, Ling W, Zhao S 2002 Human serum and glucocorticoid-inducible kinase-like kinase (SGKL) phosphorylates glycogen syntheses kinase 3 β (GSK-3β) at serine-9 through direct interaction. Biochem Biophys Res Commun 293:1191-1196
39. Sakoda H, Gotoh Y, Katagiri H, Kurokawa M, Ono H, Onishi Y, Anai M, Ogihara T, Fujishiro M, Fukushima Y, Abe M, Shojima N, Kikuchi M, Oka Y, Hirai H, Asano T 2003 Differing roles of Akt and serum- and glucocorticoid-regulated kinase in glucose metabolism, DNA synthesis, and oncogenic activity. J Biol Chem 278:25802-25807
40. Dajani R, Fraser E, Roe SM, Young N, Good V, Dale TC, Pearl LH 2001 Crystal structure of glycogen synthase kinase 3 β: structural basis for phosphate-primed substrate specificity and autoinhibition. Cell 105:721-732
41. Wyatt AW, Hussain A, Amann K, Klingel K, Kandolf R, Artune F, Grahammer F, Huang DY, Vallon V, Kuhl D, Lang F 2006 DOCA-induced phosphorylation of glycogen synthase kinase 3β. Cell Physiol Biochem 17:137-144
42. Clevers H 2006 Wnt/β-catenin signaling in development and disease. Cell 127:469-480
43. Pickart CM 2001 Mechanisms underlying ubiquitination. Annu Rev Biochem 70:503-533
44. Rock KL, Gramm C, Rothstein L, Clark K, Stein R, Dick L, Hwang D, Goldberg AL 1994 Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78:761-771
45. Orford K, Crockett C, Jensen JP, Weissman AM, Byers SW 1997 Serine phosphorylation-regulated ubiquitination and degradation of β-catenin. J Biol Chem 272:24735-24738
46. Laney JD, Hochstrasser M 1999 Substrate targeting in the ubiquitin system. Cell 97:427-430
47. Jope RS, Johnson GV 2004 The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci 29:95-102
48. Maiyar AC, Huang AJ, Phu PT, Cha HH, Firestone GL 1996 p53 stimulates promoter activity of the sgk. serum/glucocorticoid-inducible serine/threonine protein kinase gene in rodent mammary epithelial cells. J Biol Chem 271:12414-12422
49. Webster MK, Goya L, Ge Y, Maiyar AC, Firestone GL 1993 Characterization of sgk, a novel member of the serine/threonine protein kinase gene family which is transcriptionally induced by glucocorticoids and serum. Mol Cell Biol 13:2031-2040
50. Park J, Leong ML, Buse P, Maiyar AC, Firestone GL, Hemmings BA 1999 Serum and glucocorticoid-inducible kinase (SGK) is a target of the PI 3-kinase-stimulated signaling pathway. EMBO J 18:3024-3033
51. Wang D, Sul HS 1998 Insulin stimulation of the fatty acid synthase promoter is mediated by the phosphatidylinositol 3-kinase pathway. Involvement of protein kinase B/Akt. J Biol Chem 273:25420-25426
52. Aberle H, Bauer A, Stappert J, Kispert A, Kemler R 1997 β-Catenin is a target for the ubiquitin-proteasome pathway. EMBO J 16:3797-3804
53. Karim R, Tse G, Putti T, Scolyer R, Lee S 2004 The significance of the Wnt pathway in the pathology of human cancers. Pathology 36:120-128
54. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME 1999 Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857-868
55. Brunet A, Park J, Tran H, Hu LS, Hemmings BA, Greenberg ME 2001 Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol Cell Biol 21:952-965
56. Stokoe D, Stephens LR, Copeland T, Gaffney PR, Reese CB, Painter GF, Holmes AB, McCormick F, Hawkins PT 1997 Dual role of phosphatidylinositol-3,4,5- trisphosphate in the activation of protein kinase B. Science 277:567-570
57. Winer IS, Bommer GT, Gonik N, Fearon ER 2006 Lysine residues Lys-19 and Lys-49 of β-catenin regulate its levels and function in T cell factor transcriptional activation and neoplastic transformation. J Biol Chem 281:26181-26187
58. Davis M, Hatzubai A, Anderson JS, Ben-Shushan E, Fisher GZ, Yaron A, Bauskin A, Mercurio F, Mann M, Ben-Neriah Y 2002 Pseudosubstrate regulation of the SCF(β-TrCP) ubiquitin ligase by hnRNP-U. Genes Dev 16:439-451
59. Qing G, Xiao G 2005 Essential role of IκB kinase α in the constitutive processing of NF-κB2 p100. J Biol Chem 280:9765-9768
60. Imbert A, Eelkema R, Jordan S, Feiner H, Cowin P 2001 Δ N89 β-catenin induces precocious development, differentiation, and neoplasia in mammary gland. J Cell Biol 153:555-568
61. Doucas H, Garcea G, Neal CP, Manson MM, Berry DP 2005 Changes in the Wnt signalling pathway in gastrointestinal cancers and their prognostic significance. Eur J Cancer 41:365-379
62. Polakis P 2007 The many ways of Wnt in cancer. Curr Opin Genet Dev 17:45-51
63. Teuliere J, Faraldo MM, Deugnier MA, Shtutman M, Ben-Ze'ev A, Thiery JP, Glukhova MA 2005 Targeted activation of β-catenin signaling in basal mammary epithelial cells affects mammary development and leads to hyperplasia. Development 132:267-277
64. Doble BW, Woodgett JR 2003 GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci 116:1175-1186
65. Cho JH, Johnson GV 2003 Glycogen synthase kinase 3β phosphorylates τ at both primed and unprimed sites. Differential impact on microtubule binding. J Biol Chem 278:187-193
66. Eldar-Finkelman H 2002 Glycogen synthase kinase 3: an emerging therapeutic target. Trends Mol Med 8:126-132
67. Jope RS 1999 Anti-bipolar therapy: mechanism of action of lithium. Mol Psychiatry 4:117-128
68. Kozlovsky N, Belmaker RH, Agam G 2002 GSK-3 and the neurodevelopmental hypothesis of schizophrenia. Eur Neuropsychopharmacol 12:13-25
69. Phiel CJ, Wilson CA, Lee VM, Klein PS 2003 GSK-3α regulates production of Alzheimer's disease amyloid-β peptides. Nature 423:435-439